Moleculin Biotech Inc. (NASDAQ: MBRX) Stock Information | RedChip

Moleculin Biotech Inc. (NASDAQ: MBRX) Listen to this Section


$2.42
+0.1850 ( +8.30% ) 76.9K

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Market Data


Open


$2.42

Previous close


$2.23

Volume


76.9K

Market cap


$6.25M

Day range


$1.48 - $2.44

52 week range


$1.48 - $15.75

Insider Ownership Transactions

Total Amount Purchased: 202,897.00 | $ 489,996.26

Date Type Amount Purchased Purchaser
2023-12-27 Buy 14493.00 George Robert E.
2023-12-27 Buy 188404.00 KLEMP WALTER V

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 25, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
8-k 8K-related 43 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
8-k 8K-related 22 Jun 14, 2024
8-k 8K-related 16 May 16, 2024
8-k 8K-related 17 May 15, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.